Yarrow Bioscience, Inc. SEC filings YARW
Yarrow Bioscience, Inc. has 682 filings in SEC EDGAR's recent list, going back to Jan 7, 2013. Its latest annual report, Form ARS, was filed on Jun 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 30, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Oct 30, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Oct 30, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Oct 30, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Oct 30, 2026 | Oct 29, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 7, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 17, 2026 | — |
| 8-K |
Current report
Material agreement
|
Sep 14, 2026 | Sep 10, 2026 |
| 424B5 | Prospectus supplement | Sep 11, 2026 | — |
| 424B5 | Prospectus supplement | Sep 11, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 10, 2026 | Sep 10, 2026 |
| EFFECT | Filing | Aug 19, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| POS AM | Filing | Aug 14, 2026 | — |
| 8-K/A |
Amended current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2026 | Jul 24, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 7, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Aug 5, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 4, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 3, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 30, 2026 | — |
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Other events
|
Jul 30, 2026 | Jul 29, 2026 |
| 3 | Initial insider ownership | Jul 30, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 27, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 27, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 27, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 27, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 27, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 27, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 27, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 27, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 27, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 27, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 27, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 29, 2026 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 28, 2026 | Jul 24, 2026 |
| 4 | Insider transaction | Jul 24, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 24, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 24, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 24, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 21, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 20, 2026 | Jul 16, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 14, 2026 | — |
| 425 | Filing | Jul 14, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 14, 2026 | Jul 14, 2026 |
| 425 | Filing | Jul 10, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 10, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| ARS | Annual report to shareholders | Jun 16, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Jun 15, 2026 | — |
| 424B3 | Prospectus | Jun 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 15, 2026 | — |
| S-4/A | Filing | Jun 3, 2026 | — |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 21, 2026 | May 21, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| S-4/A | Filing | Apr 28, 2026 | — |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| S-4 | Registration for a merger or exchange | Mar 31, 2026 | — |
| 8-K |
Current report
Listing notice
|
Mar 11, 2026 | Mar 11, 2026 |
| 10-K | Annual report | Feb 27, 2026 | Dec 31, 2025 |
| DRS | Filing | Jan 30, 2026 | — |
| 425 | Filing | Jan 30, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jan 30, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 425 | Filing | Dec 17, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure
|
Dec 17, 2025 | Dec 17, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 12, 2025 | Dec 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| ARS | Annual report to shareholders | Nov 12, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Nov 12, 2025 | Dec 12, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Listing notice
|
Sep 12, 2025 | Sep 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 14, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 30, 2025 | Jul 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 2, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 19, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Jan 23, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 23, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 23, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 23, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 16, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Dec 23, 2024 | Dec 23, 2024 |
| S-8 | Employee stock plan registration | Dec 19, 2024 | — |
| 4 | Insider transaction | Dec 13, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 13, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 13, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 13, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 13, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 13, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 12, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 30, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| ARS | Annual report to shareholders | Nov 12, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Nov 12, 2024 | Dec 12, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Sep 12, 2024 | Sep 12, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 1, 2024 |
| EFFECT | Filing | Mar 14, 2024 | — |
| CORRESP | Letter to the SEC | Mar 12, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2024 | — |
| S-3 | Shelf registration | Mar 1, 2024 | — |
| S-8 | Employee stock plan registration | Mar 1, 2024 | — |
| 10-K | Annual report | Mar 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 2, 2024 | — |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 3, 2024 | Dec 29, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 3, 2024 | Dec 29, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 13, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 13, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 13, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 13, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 13, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 13, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 13, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 13, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 13, 2023 |
| S-8 | Employee stock plan registration | Dec 13, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 13, 2023 | Dec 11, 2023 |
| 4 | Insider transaction | Dec 4, 2023 | Nov 30, 2023 |
| EFFECT | Filing | Nov 22, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- YARW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1566044
- Former names
- VYNE Therapeutics Inc. (until Jul 24, 2026); Menlo Therapeutics Inc. (until Sep 2, 2020); Menlo Therapeutics, Inc. (until Jan 31, 2018); Tigercat Pharma, Inc. (until Jan 7, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.